In vivo and in vitro functional characterization of Andersen's syndrome mutations.
about
Renal, ocular, and neuromuscular involvements in patients with CLDN19 mutations.Kir2.6 regulates the surface expression of Kir2.x inward rectifier potassium channelsKCNJ2 mutations in arrhythmia patients referred for LQT testing: a mutation T305A with novel effect on rectification properties.Hypokalemic periodic paralysis: a model for a clinical and research approach to a rare disorder.Mechanisms underlying Andersen's syndrome pathology in skeletal muscle are revealed in human myotubes.Electrophysiological mechanisms of ventricular arrhythmias in relation to Andersen-Tawil syndrome under conditions of reduced IK1: a simulation study.Membrane dysfunction in Andersen-Tawil syndrome assessed by velocity recovery cycles.
P2860
Q34639658-9B4B0965-E23C-4E14-9013-18E7AF77F453Q34685019-BEBBC291-EF14-48D1-8A2F-47E75B6F2680Q35793717-DC363AB5-0D70-42CC-A55A-DAAE4F0614D1Q36774708-6436BAF3-F7B7-432A-B986-7B2542724613Q46135689-8BE94D91-1D21-4C92-97B1-B045BBC9D85DQ46623400-805D63BF-2BB7-4C07-9B61-DDFC84E4D21EQ50795207-749B8C7B-44F7-4272-A3F0-FC9BCB8BABF8
P2860
In vivo and in vitro functional characterization of Andersen's syndrome mutations.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
In vivo and in vitro functional characterization of Andersen's syndrome mutations.
@en
type
label
In vivo and in vitro functional characterization of Andersen's syndrome mutations.
@en
prefLabel
In vivo and in vitro functional characterization of Andersen's syndrome mutations.
@en
P2093
P2860
P1476
In vivo and in vitro functional characterization of Andersen's syndrome mutations
@en
P2093
Alain Furby
Bertrand Fontaine
Carole Sereni
Emmanuel Fournier
Guillaume Bassez
Jacques Barhanin
Marie-Madeleine Larroque
Matthew R Donaldson
Saïd Bendahhou
P2860
P304
P356
10.1113/JPHYSIOL.2004.081620
P407
P577
2005-04-14T00:00:00Z